Pregnancy and primary pulmonary hypertension : successful outcome with epoprostenol therapy.

Autor: Stewart R, Tuazon D, Olson G, Duarte AG, Stewart, R, Tuazon, D, Olson, G, Duarte, A G
Zdroj: CHEST; Mar2001, Vol. 119 Issue 3, p973-975, 3p
Abstrakt: Primary pulmonary hypertension (PPH) associated with pregnancy carries a high maternal mortality rate. Short-term epoprostenol infusion has been demonstrated to improve the hemodynamic profile in patients with PPH. We report a successful maternal-fetal outcome with epoprostenol therapy during pregnancy, cesarean section, and postpartum in a patient with PPH. Epoprostenol therapy did not produce any physical or developmental abnormalities in the fetus. A favorable maternal-fetal outcome may occur with a multidisciplinary approach. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index